Prescription Required.Why?
A sulfonylurea drug that stimulates the pancreas to release more insulin.
A biguanide drug that improves insulin sensitivity and reduces glucose production in the liver.
Type 2 diabetes mellitus, when diet and exercise alone are not enough to control blood sugar levels.
Used in patients who are not adequately controlled on metformin alone or gliclazide alone.
Gliclazide increases insulin secretion from the pancreas, while metformin enhances insulin sensitivity and decreases hepatic glucose production. This combined action leads to improved blood glucose control.
Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.
Dosage should be determined by a healthcare professional based on individual needs and response.
Typically started at a low dose and gradually increased as needed.
Taken with meals to minimize gastrointestinal side effects.
Hypoglycemia (low blood sugar): Symptoms include sweating, dizziness, shakiness, and confusion.
Gastrointestinal issues: Nausea, vomiting, diarrhea, and abdominal pain (more common with metformin).
Lactic acidosis (rare but serious complication with metformin, especially in patients with kidney problems).
Allergic reactions (rash, itching).
Alcohol consumption should be limited as it can increase the risk of hypoglycemia and lactic acidosis.
Caution advised if experiencing hypoglycemia, as it can impair alertness and coordination.
Generally not recommended during pregnancy and breastfeeding. Discuss with your doctor.
Not usually prescribed for children.
Dosage adjustment or contraindicated in patients with severe kidney disease (due to risk of lactic acidosis with metformin).
Use with caution in patients with liver disease. Liver function tests may be required.
Consult your physician or pharmacist for detailed information and references.
Package insert provided with the medication.
Reputable medical websites and databases (e.g., the FDA, etc.)
